Cargando…

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study

Objective To determine if the use of pioglitazone is associated with an increased risk of incident bladder cancer in people with type 2 diabetes. Design Retrospective cohort study using a nested case-control analysis. Setting Over 600 general practices in the United Kingdom contributing to the gener...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azoulay, Laurent, Yin, Hui, Filion, Kristian B, Assayag, Jonathan, Majdan, Agnieszka, Pollak, Michael N, Suissa, Samy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365142/ https://www.ncbi.nlm.nih.gov/pubmed/22653981 http://dx.doi.org/10.1136/bmj.e3645

Ejemplares similares

Pioglitazone use and risk of bladder cancer: population based cohort study
por: Tuccori, Marco, et al.
Publicado: (2016)

The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes
por: Smiechowski, Brielan B., et al.
Publicado: (2013)

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
por: Douros, Antonios, et al.
Publicado: (2018)

Response to Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes. Diabetes Care 2013;36:124–129
por: Suissa, Samy, et al.
Publicado: (2013)

Cardiac glycosides use and the risk of lung cancer: a nested case–control study
por: Couraud, Sébastien, et al.
Publicado: (2014)

Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study
por: Lapi, Francesco, et al.
Publicado: (2013)

Response to Yang and Chan. Metformin and the Risk of Cancer: Time-Related Biases in Observational Studies. Diabetes Care 2012;35:2665–2673
por: Suissa, Samy, et al.
Publicado: (2013)

Response to Bodmer et al. Metformin and the Risk of Cancer: Time-Related Biases in Observational Studies. Diabetes Care 2012;35:2665–2673
por: Suissa, Samy, et al.
Publicado: (2013)

Metformin and the Risk of Cancer: Time-related biases in observational studies
por: Suissa, Samy, et al.
Publicado: (2012)

A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case–control study
por: Azoulay, Laurent, et al.
Publicado: (2012)

Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study
por: Faillie, Jean-Luc, et al.
Publicado: (2014)

Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study
por: Pradhan, Richeek, et al.
Publicado: (2022)

The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
por: Song, Sun Ok, et al.
Publicado: (2012)

Long-Term Use of Angiotensin Receptor Blockers and the Risk of Cancer
por: Azoulay, Laurent, et al.
Publicado: (2012)

Pioglitazone, bladder cancer, and detection bias
por: Dolin, Paul
Publicado: (2014)

Pioglitazone Induces Dysplastic Urothelial Changes in Urinary Bladder of Experimental Diabetes
por: Abdel-Hamid, Ahmed A. M., et al.
Publicado: (2021)

Pioglitazone does not increase the risk of type II diabetes in patients with bladder cancer: A retrospective study
por: DONG, YOUHONG, et al.
Publicado: (2016)

A retrospective study to assess the risk of bladder cancer in type-2 diabetic patients treated with pioglitazone
por: Agrawal, Prabhat, et al.
Publicado: (2021)

The Risk of Bladder Cancer in Type 2 Diabetes Mellitus with Combination Therapy of SGLT-2 Inhibitors and Pioglitazone
por: Li, Yan-Rong, et al.
Publicado: (2021)

Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: a nested case–control study
por: Woo, Min-Hee, et al.
Publicado: (2019)

Concurrent Use of Benzodiazepines and Antidepressants and the Risk of Motor Vehicle Accident in Older Drivers: A Nested Case–Control Study
por: Fournier, Jean-Pascal, et al.
Publicado: (2015)

The Association of Pioglitazone and Urinary Tract Disease in Type 2 Diabetic Taiwanese: Bladder Cancer and Chronic Kidney Disease
por: Lee, Mei-Yueh, et al.
Publicado: (2014)

Subclinical hypothyroidism and the risk of cancer incidence and cancer mortality: a systematic review
por: Gómez-Izquierdo, Juan, et al.
Publicado: (2020)

Pioglitazone and sulfonylureas: effectively treating type 2 diabetes
por: Hanefeld, M
Publicado: (2007)

Risk management in the treatment of type 2 diabetes with pioglitazone
por: Derosa, Giuseppe, et al.
Publicado: (2009)

Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study
por: Yang, Shao-ling, et al.
Publicado: (2018)

Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
por: Filipova, Elena, et al.
Publicado: (2017)

Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
por: Hicks, Blánaid M, et al.
Publicado: (2018)

Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes
por: Qu, Hua, et al.
Publicado: (2017)

Evaluation of exposure to pioglitazone and risk of prostate cancer: a nested case–control study
por: Boxall, Naomi, et al.
Publicado: (2016)

Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes
por: Yamanouchi, Toshikazu
Publicado: (2010)

Pioglitazone in the Treatment of Type 2 Diabetes: Safety and Efficacy Review
por: Desouza, Cyrus V., et al.
Publicado: (2010)

Pioglitazone and thyroid cancer risk in patients with type 2 diabetes
por: Tseng, Chin-Hsiao
Publicado: (2014)

Pioglitazone and Bladder Cancer: A population-based study of Taiwanese
por: Tseng, Chin-Hsiao
Publicado: (2012)

Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study
por: Gupta, Sunil, et al.
Publicado: (2015)

Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study
por: Martinez, Carlos, et al.
Publicado: (2010)

Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis
por: Yan, Huaqing, et al.
Publicado: (2018)

Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?
por: Jagat J, Mukherjee, et al.
Publicado: (2020)

A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes
por: Dorkhan, Mozhgan, et al.
Publicado: (2007)

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
por: Schwartz, Stanley S
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fgfbemtepr70kj59suubvsngj2